Glimepiride is a novel sulfonylurea for the treatment of type II-diabetic patients exhibiting different receptor binding kinetics to B-cell membranes with 8-9-fold higher kof f rate and 2.5-3-fold higher kon rate compared to glibenclamide (see accompanying paper (Miiller, G. et al. (1994) Biochim. Biophys. Acta 1191, 267-277)). To elucidate the molecular basis for this differential behaviour of glimepiride and glibenclamide, direct photoaffinity labeling studies using fl-cell tumor membranes were performed. 
Introduction
Using direct photoaffinity labeling of fl-cell tumor membranes (Kramer et al. [1] ), HIT T15 cell membranes (Aguilar-Bryan et al. [2, 3] ) and RINm5F cell membranes (De Weille et al. [4] ) with 3H-or 125I-labeled glibenclamide analogues, the high-affinity sulfonylurea binding site has been attributed to a 140 kDa membrane protein (for a recent review, see Ashcroft and Ashcroft [5] ). The relative ability of various sulfonylureas to displace [3H]glibenclamide from /3-cell membranes parallels their ability to block ATP-regulated K+-channels, to stimulate insulin release and to cause reduction of the blood sugar [6] [7] [8] . Whether the 140 kDa glibenclamide receptor protein is itself (part of) the ATP-regulated K+-channel or whether it is a separate (transiently or permanently) channel-associated protein, has not yet been established.
So far, no reports are available concerning the characterization of binding protein(s) for sulfonylureas of different structure. Since the novel sulfonylurea, glimepiride (Geisen [9] ), exhibits a significantly higher exchange rate with the sulfonylurea receptor but a 2.5-3-fold lower binding affinity compared to glibenclamide, we investigated in the present study the molecular interaction of glimepiride with the sulfonylurea receptor by direct photoaffinity labeling with 
Materials and methods
Materials. [3,5-3H] benzoic acid N-hydroxysuccinimide ester (50.8 Ci/mmol) according to the procedure described previously (Kramer [10] ). Biolute S was bought from Zinsser Analytik, Frankfurt, Germany. Chemicals for electrophoresis were provided from Serva, Heidelberg, Germany. Molecular mass marker proteins for electrophoresis were obtained from Sigma, Deisenhofen, Germany. All other reagents and materials were purchased as described in the accompanying report [11] . Rats of the strain NEDH (New and protein was precipitated as published [12] . For photoaffinity labeling of/3-cell membranes and solubilized /3-cell membrane proteins, the 75 000 x g pellet, obtained during preparation of the/3-cell tumor membranes, was suspended in 100 mM sodium phosphate buffer (pH 7.4). For labeling of solubilized #-cell membrane proteins, CHAPS or Triton X-100 was added (final concn. 1% w/v). After incubation (60 min, 4°C), the supernatant obtained after centrifugation (48 000 x g, 30 min) was used for photoaffinity labeling. For this, 600 /zg of /3-cell membrane protein (membranes or solubilized membrane proteins) was incubated (60 min, 20°C) in a total volume of 200 /xl with 25-60 nM (0.3-0. 4 in the photochemical reactor described above, the samples were diluted with 1 ml of 10 mM Tris-Hepes buffer (pH 7.4), 4 mM EDTA, 4 mM iodoacetamide, 4 mM PMSF, centrifuged (48 000 x g, 30 rain) and protein was precipitated as above. For photoaffinity labeling with monochromatic light, the samples were irradiated with narrow-bandwidth light for 10 min in a rectangular cuvette (1 x 0.1 cm) of quartz glass in a sample chamber of a Hitachi F-3000 fluorimeter (Hitachi, Tokyo, Japan) equipped with a 150 W xenon arc lamp. Wavelengths were selected with the excitation monochromator. After irradiation, 100-tzl aliquots (40 /zg) were removed and protein was precipitated with 500 tzl of dioxane.
For photoaffinity labeling of RINm5F cells, (0.5-1)-10 6 cells were incubated (10 min, 20°C) with 25 nM [3H]glimepiride (0.5 /xCi) or [3H]glibenclamide (0.5 /~Ci) in the dark and subsequently irradiated at 254 nM for 2 min. The cells were then washed twice with 1 ml of 10 mM sodium phosphate buffer (pH 7.4), 4 mM PMSF, 4 mM EDTA, 4 mM iodoacetamide. After centrifugation (48000 × g, 60 min), the pellets were resuspended in 100/xl H20 and proteins were precipitated and analyzed by SDS-PAGE.
SDS-PAGE.
The dried protein precipitates were dissolved in 70 /~1 of 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 5% 2-mercaptoethanol, 0.005% Bromophenol blue by shaking on a mixer for 60 min. After centrifugation (15000 ×g, 10 min), the supernatants were submitted to SDS-PAGE on 150 × 180 × 1.5 mm slab gels as described (Kramer et al. [13, 14] ). After fixing and staining, the gels were scanned with a CD-50 densitometer, Desaga, Heidelberg, Germany and then scanned for radioactivity by liquid scintillation counting of 2-mm gel pieces after digestion of proteins with Biolute S.
Miscellaneous. Culture of RINm5F ceils, preparation of /3-cell tumor membranes and RINm5F cell membranes and Scatchard plot analysis of specific [3H]glimepiride and [3H]glibenclamide binding to RINm5F cell membranes or solubilized RINm5F cell membrane proteins using rapid filtration and precipitation with poly(ethylene glycol) were performed as described in the accompanying report [11] .
Results

Competitive Scatchard plot analysis of [ 3H]glimepiride and [ 3H]glibenclamide binding
Competitive Scatchard plot analysis ( (Fig. 2) . The suitability of [3H]glibenclamide as a direct photoaffinity probe upon irradiation with UV-light at 254 nm or 300 nm has been demonstrated previously (Kramer et al. [1] ) and aromatic azido-compounds are well established as nitrene-generating photoaffinity probes (Bayley [19] ). Owing to the a,0-unsaturated carbonyl function in the molecule, a photocatalyzed activation of glimepiride via a n-zr* transition state seemed possible (Martyr and Benisek [20] ). Therefore, at first the ability of [3H]glimepiride to act as a direct photoaffinity probe was investigated by irradiation of human [10] ). After photoaffinity labeling of 0-cell membranes, the membranes were washed and polypeptides were separated by SDS-PAGE followed by determination of radioactively labeled polypeptides after slicing of the gels into 2-ram pieces.
[3H]Glibenclamide was predominantly incorporated into two membrane polypeptides with apparent M r of Qualitatively, the same labeling pattern was obtained using the probes in the concentration range of 1-10 nM, but the incorporation yields were rather low. In further control experiments, no differences in the labeling patterns of a distinct sulfonylurea photoprobe was found up to concentrations of 100 nM.
In order to elucidate whether the binding proteins for glibenclamide and glimepiride identified in fl-cell membranes are also physiologically involved in binding of sulfonylureas, we performed photoaffinity labeling studies with RINm5F cells using [3H]glibenclamide and [3H]glimepiride. Since the wavelength necessary for photocrosslinking of these ligands may damage living cells, we measured in a first series of experiments the influence of irradiation on cell viability. Irradiation of RINm5F cells (10.75.10 6 cells/ml) was performed in a Rayonet RPR-100 photochemical reactor at a distance of 10 cm from the lamps using either 16 RPR-2530 .~ or 16 RPR-3000 ,~ lamps with subsequent determination of cell viability by Trypan blue exclusion. Table 1 shows that within the irradiation times necessary for sufficient photoaffinity labeling with 
-
Effect of solubilization on photoaffinity labeling of the glimepiride-binding and glibenclamide-binding proteins
Since on the one hand glimepiride inhibited labeling of the 140 kDa protein by [3H]glibenclamide without an obvious direct binding to the 140 kDa protein and on the other hand glibenclamide inhibited labeling of the 65 kDa protein by [3H]glimepiride, it seemed possible that both proteins are subunit constituents of the sulfonylurea receptor complex interacting with each other in a cooperative manner. Sulfonylureas of different structure may have different access to these proteins embedded in the/3-cell plasma membrane. Consequently, we examined whether photoaffinity labeling of the respective proteins is dependent on the intact structure of the membrane or resists solubilization by detergent. non-competitive to competitive type of inhibition of [3H]glimepiride-binding by glibenclamide and vice versa in Scatchard plot analysis using heterologous ligands [15] [16] [17] . The steady-state and kinetic binding experiments (see accompanying paper [11] ) as well as the competitive Scatchard analyses and photoaffinity labeling studies using solubilized membranes hint to an attenuating effect of the membrane environment or of the interaction with the glibenclamide binding protein on the affinity or accessibility of the glimepiride binding protein which can be overcome by solubilization.
Discussion
A 140 kDa protein in /3-cell tumor membranes has been demonstrated previously to be photoaffinity labeled by [3H]glibenclamide with high specificity and selectivity (Kramer et al. [1] ). With an iodinated analogue of glibenclamide, 5-iodo-2-hydroxyglibenclamide, four polypeptides with M r = 65 000, 55 000, 43 000 and 30000 were additionally labeled in HIT T15 cells [2] . Differential photolabeling by various sulfonylureas revealed half-maximal displacements (and K i values calculated thereof) for the 30-65 kDa proteins in the low micromolar range. Consequently, these proteins were attributed to low-affinity binding sites (Nelson et al. [21] ). Photoaffinity labeling of /3-cell tumor membranes with [3H]glimepiride led to an exclusive incorporation of the photoprobe into a 65 kDa protein under conditions where [3H]glibenclamide labeled the 140 kDa protein. Since glimepiride was bound by/~-cell tumor and RINm5F cell membranes with K a values in the low nanomolar range (see accompanying paper [11] ), and since labeling of the 65 kDa protein was inhibited dose-dependently by glibenclamide and tolbutamide, this protein seems to be the high-affinity binding site for glimepiride.
The failure of the 65 kDa protein to become photolabeled by [3H]glibenclamide using ]3-cell membranes may have different reasons.
(i) It may be argued that the photochemistry of the 2-methoxy-5-chlorobenzene ring in glibenclamide and of the 3-ethyl-4-methyl-3-pyrrolin-2-on ring in glimepiride differs completely with respect to addition to double bonds and insertion into single bonds at the binding site of the sulfonylurea binding protein(s). However, since both compounds have a similar structure and space-filling and a nearly identical wavelength dependence for photoincorporation into albumin strongly suggesting a similar photochemical mechanism of covalent crosslinking, this explanation is rather unlikely.
( (iii) The respective receptor protein(s) may be inaccessible for the sulfonylureas from the outer face of the membrane. This view is strengthened by the observation that disruption of the membrane barrier by solubilization greatly increased the intensity of photolabeling of the 65 kDa protein by [3H]glimepiride which was accompanied by a decrease of the K d value for glimepiride from 1.46 nM with /3-cell membranes to 0.55 nM with solubilized /3-cell membrane proteins (see accompanying paper [11] Thus, the capability of the two sulfonylureas to gain access to the 65 kDa and 140 kDa binding polypeptides in the fl-cell membrane may rely on the spontaneous insertion of the compounds into the phospholipid bilayer. Interestingly, the partitioning behaviour between an octanol and water phase varies widely within the class of sulfonylurea drugs (Panten et al. [8] ). A rapid membrane partitioning of glimepiride may prevent its photocrosslinking to the 140 kDa glibenclamide binding protein if this is amenable to photolabeling only from the outer face of the membrane. Alternatively, the presence of detergent may simply decrease the binding affinity of the 140 kDa and increase the affinity of the 65 kDa sulfonylurea receptor. We think this possibility less likely since, according to competitive photolabeling, the binding selectivity of the 65 kDa protein was not altered after solubilization arguing against gross conformational changes.
The photolabeling studies described above and those performed by others clearly indicate, that the labeling patterns of sulfonylurea-binding proteins greatly depends on the structure of the sulfonylurea photoprobe used. With [3H]glibenclamide, the radiolabeled form of the therapeutically used sulfonylurea, only two polypeptides of Mr = 140000 and 33000 were labeled (Kramer et al. [11] ). Use of 5-iodo-2-hydroxyglyburide, where the 2-methoxy-5-chlorobenzene ring in glibenclamide was substituted by the more bulky and hydrophobic 5-iodo-2-hydroxybenzene ring, led to labeling of 140 kDa, 65 kDa, 55 kDa and 30 kDa polypeptides with a strong preference for the 140 kDa binding protein (Nelson et al. [21] ). The sulfonylurea [1251135623 containing a 2-hydroxy-5-halobenzene ring of identical photochemical behaviour like glibenclamide or 5-iodo-2-hydroxyglibenclamide (AquilarBryan et al. [2] ) led to prominent labeling of a 65 kDa protein in /3-cell membranes, exclusively, and also in intact HIT T15 cells (Niki et al. [22] [21] ) exclude the hypothesis that the 140 kDa protein is a dimer of glibenclamide-binding subunits of M r = 65 000 as suggested by Niki et al. [22] ). With the exception of the 33 kDa protein, the labeling of the sulfonylurea-binding proteins, labeled to different extent by the above-mentioned photolabile glibenclamide and glimepiride probes, was concentration-dependently and specifically inhibited by unlabeled sulfonylureas. These findings with /3-cell membranes are reflected by photoaffinity labeling studies in intact cells. Whereas [22] ).
From the relationship between structure and photolabeling patterns of different sulfonylureas (Table 2) , it becomes evident that the photoprobes predominantly labeling the 140 kDa protein contain an cyclohexylamino moiety (glibenclamide, 5-iodo-2-hydroxyglibenclamide), whereas the compounds preferably labeling the 65 kDa protein contain a 4-trans-methylcyclohexyl amine residue (glimepiride, [125I]35623). This structural difference in the sulfonylurea molecule seems to determine binding to the 65 or 140 kDa sulfonylurea binding proteins, respectively. These data strongly support the hypothesis, that the functional sulfonylurea receptor within the /3-cell membrane is composed of subunits, among them the 140 kDa and 65 kDa proteins. The hypothesis that the /3-cell sulfonylurea receptor consists of a complex built up by several subunits is a matter of controversy at the moment (see Ozanne et al. [24] vs. Skeer et al. [25] and Nelson et al. [26] ). The finding of a functional M r = 134000-166000 of the sulfonylurea receptor in the native as well as solubilized state as determined by target size analysis and gel filtration, respectively, (Skeer et al. [25] ) is not in conflict with our results, since the functional molecular mass was determined using binding and photoaffinity labeling of [3H]glibenclamide. We also observed a linear Scatchard plot for glibenclamide binding and an almost exclusive incorporation of [3H]glibenclamide into the 140 kDa protein arguing against allosteric interactions between the glibenclamide-binding and glimepiride-binding proteins if only one binding site is occupied. Further evidence for this interpretation will require radiation inactivation of /~-cell membranes followed by competitive Scatchard plot analysis of [3H]glibenclamide binding in the presence of glimepiride and vice versa or gelfiltration of solubilized [3H]glibenclamide-labeled /3-cell membrane proteins in the presence of glimepiride and vice versa.
Despite the fact that [3H]glimepiride and [3H]glibenclamide were crosslinked to two distinct proteins, they competed each other for photolabeling suggesting a direct interaction of both sulfonylurea binding proteins as subunits of a common receptor complex. According to this hypothesis, occupancy of one binding protein decreases the binding affinity of the other in a negative cooperative manner. Thus, the two sulfonylureas seem to inhibit steady-state binding or photoaffinity labeling of each other by allosteric mechanisms rather than by competition for the same binding site. This interpretation is substantiated by Scatchard plot analysis when [3H]glimepiride was diluted with unlabeled glibenclamide and vice versa. However, this does not explain the discrepancy between the higher potency of glimepiride in inhibiting photolabeling and its lower potency in competing equilibrium binding compared to glibenclamide. Besides other factors, the exchange rate of the ligand with the receptor determines the efficiency of photoaffinity labeling and the inhibitory effect of competing ligands (Pomerantz et al. [27] ). In fact, glimepiride binding to/t-cell membranes is characterized by drastically higher dissociation and association rates compared to glibenclamide. The resulting ~ 3-fold higher exchange rate of glimepiride correlates well with the 3-fold lower concentration of this drug required for half-maximal inhibition of photolabeling using [3H]glibenclamide.
The role for the sulfonylurea receptor of the 33 kDa protein being also photolabelled by [3H]glibenclamide and exclusively by the radiolabeled azidobenzoyl-derivative of glibenclamide, N3-[3H]33055, remains unclear (see Table 2 ). Unlabeled N3-33055, however, was able to displace [3H]glibenclamide from /3-cell membranes in a competition binding assay. The concentrations necessary were about 100-fold higher than those for unlabeled glimepiride or glibenclamide (data not shown). Attachment of a bulky aromatic residue, such as the azidobenzoyl group, to the aromatic benzamido radical of the glibenclamide molecule leads to a strong decrease in affinity to the sulfonylurea receptor, a finding also observed with a fluorescent fluorescein-derivative of glibenclamide (Miiller, G., unpublished resuits).
We do not know the physiological relevance of the differential photoaffinity labeling of sulfonylureas of different structure. Since the identity of the 140 and 65 kDa components of the putative sulfonylurea receptor complex is unknown so far, it remains unclear whether one or both of them are constituents of the ATP-dependent K÷-channel in the/3-cell plasma membrane or interact as regulatory proteins with the channel in a transient manner. Obviously, occupancy of one component seems to be sufficient for channel inhibition and, as a consequence, stimulation of insulin release. Interestingly, for Ca2÷-channels in various tissues characterized with different (photo)-affinity probes, similar molecular masses of 140-170 kDa, 52-60 kDa and 32-35 kDa have been described for the protein components of these channels (Glossmann et al. [28] 5; Galizzi et al. [29] ; Glossmann et al. [30] ). Their relationship to the corresponding sulfonylurea-labeled polypeptides has to be elucidated.
